Efficacy and safety of low-dose tirofiban plus dual antiplatelet therapy in acute cerebral infarction beyond the thrombolysis window: a non-randomized trial with preliminary findings.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.